No association between EGF gene polymorphism and gastric cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 14, Issue 10, 2005, Pages 2454-2456

  Goto, Yasuyuki ^a   Ando, Takafumi ^a   Goto, Hidemi ^a   Hamajima, Nobuyuki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; EPIDERMAL GROWTH FACTOR;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STOMACH CANCER;

ADULT; AGED; AGED, 80 AND OVER; EPIDERMAL GROWTH FACTOR; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; STOMACH NEOPLASMS;

EID: 26444475950     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0401     Document Type: Article

References (14)

1. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin 1999;49:33-64.
2. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process - First American Cancer Society award lecture on cancer epidemiology and prevention. Cancer Res 1992;52:6735-40.
3. Shahbazi M, Pravica V, Nasreen N, et al. Association between functional polymorphism in EGF gene and malignant melanoma. Lancet 2002;359:397-401.
4. Bhowmick DA, Zhuang Z, Wait SD, Weil RJ. A functional polymorphism in EGF gene is found with increased frequency in glioblastoma multiforme patients and is associated with more aggressive disease. Cancer Res 2004;64:1220-3.
5. Baselga J. Why the epidermal growth factor receptor? The rationale for cancer therapy. Oncologist 2002;7:2-8.
6. Goel S, Mani S, Perez-Soler R. Tyrosine kinase inhibitors: a clinical perspective. Curr Oncol Rep 2002;4:9-19.
7. Raymond E, Favre S, Armand JP. Epidermal growth factor receptor tyrosine kinase as a target for anticancer therapy. Drugs 2000;60:15-23.
8. Danielsen AJ, Maihle NJ. The EGF/ErbB receptor family and apoptosis. Growth Factors 2002;20:1-15.
9. Lonardo F, Dragnev KH, Freemantle SJ, et al. Evidence for the epidermal growth factor receotor as a target for lung cancer prevention. Clin Cancer Res 2002;8:54-60.
10. Hamai Y, Matsumura S, Matsusaki K, et al. A single nucleotide polymorphism in the 5′ untranslated region of the EGF gene is associated with occurrence and malignant progression of gastric cancer. Pathobiology 2005;72:133-8.
11. Katsuda N, Hamajima N, Tamakoshi A, et al. Helicobacter pylori seropositivity and the myeloperoxidase G-463A polymorphism in combination with interleukin 1B C-31T in Japanese health checkup examinees. Jpn J Clin Oncol 2003;33:192-7.
12. Goto Y, Ando T, Yamamoto K, et al. Association between serum pepsinogens and polymorphism of PTPN11 encoding SHP-2 among Helicobacter pylori seropositive Japanese. Int J Cancer. 2005 July 19; [Epub ahead of print].
13. Nakanura K, Sugano H, Takagi K. Carcinoma of the stomach: Its histogenesis and histological appearance. Gann 1968;59:251-8.
14. McCarron SL, Bateman AC, Theaker JM, Howell WM. EGF +61 gene polymorphism and susceptibility to and prognostic markers in cutaneous malignant melanoma. Int J Cancer 2003;107:673-5.